|
Video: What is a Stock Split?
|
|
IGC Pharma is a clinical-stage pharmaceutical company engaged in developing both prescription drugs and over-the-counter products. Co. has two segments: Life Sciences and Infrastructure. Co. develops formulations for treating diseases and conditions through its Life Science segment. Co.'s main drug candidate, IGC-AD1, is an oral therapy for the treatment of agitation associated with Alzheimer's disease. Co. also has a line of consumer product such as Holief, which includes gummies and pain relief creams for women experiencing premenstrual syndrome and menstrual cramps. Co.'s infrastructure business includes: execution of construction contracts and rental of heavy construction equipment. According to our IGC Pharma stock split history records, IGC Pharma has had 3 splits. | |
|
IGC Pharma (IGC) has 3 splits in our IGC Pharma stock split history database. The first split for IGC took place on October 06, 1998. This was a 4111 for 1000
split, meaning for each 1000
shares of IGC owned pre-split, the shareholder now owned 4111 shares. For example, a 1000 share position pre-split, became a 4111 share position following the split. IGC's second split took place on October 20, 1998. This was a 1 for 5
reverse split, meaning for each 5
shares of IGC owned pre-split, the shareholder now owned 1 share. For example, a 4111 share position pre-split, became a 822.2 share position following the split. IGC's third split took place on April 19, 2013. This was a 1 for 10 reverse split, meaning for each 10 shares of IGC owned pre-split, the shareholder now owned 1 share. For example, a 822.2 share position pre-split, became a 82.22 share position following the split.
When a company such as IGC Pharma splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as IGC Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IGC Pharma stock split history from start to finish, an original position size of 1000 shares would have turned into 82.22 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IGC Pharma shares, starting with a $10,000 purchase of IGC, presented on a split-history-adjusted basis factoring in the complete IGC Pharma stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$0.83 |
|
End price/share: |
$0.40 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-51.81% |
|
Average Annual Total Return: |
-7.04% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,820.01 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
10/06/1998 | 4111 for 1000
| 10/20/1998 | 1 for 5
| 04/19/2013 | 1 for 10 |
|
|